Alcocer-Varela J, Alarcón-Riquelme M, Laffón A, Sánchez-Madrid F, Alarcón-Segovia D
Department of Immunology and Rheumatology, Instituto Nacional de la Nutrición Salvador Zubirán, Mexico City.
J Autoimmun. 1991 Dec;4(6):935-45. doi: 10.1016/0896-8411(91)90056-i.
Using various monoclonal antibodies to T cell activation molecules it has been shown that purified T cells from patients with active systemic lupus erythematosus overexpress the 4F2, IL-2R (CD25), HLA-DR and T10 antigens. T cells from patients with inactive disease had increased expression of VLA-1 and HLA-DR. Increased T10 expression on T cells from patients with active disease correlated inversely with the production of IL-2, whereas expression of CD25 was slightly increased after 3-day culture with either PHA or anti-CD3. These results provide further evidence of the in vivo activation of T cells in SLE and suggest that such activation comes slowly to a halt upon disease remission.
运用多种针对T细胞活化分子的单克隆抗体已表明,来自活动性系统性红斑狼疮患者的纯化T细胞过度表达4F2、IL-2R(CD25)、HLA-DR和T10抗原。非活动性疾病患者的T细胞VLA-1和HLA-DR表达增加。活动性疾病患者T细胞上T10表达的增加与IL-2的产生呈负相关,而在用PHA或抗CD3进行3天培养后,CD25的表达略有增加。这些结果为系统性红斑狼疮中T细胞的体内活化提供了进一步证据,并表明这种活化在疾病缓解时会缓慢停止。